Vaccination with liposomal poly(I:C) induces discordant maturation of migratory dendritic cell subsets and anti-viral gene signatures in afferent lymph cells

Vaccine

Volumn 32, Issue 47, 2014, Pages 6183-6192

  Neeland, Melanie R ^a   Elhay, Martin J ^b,c   Meeusen, Els N T ^a   de Veer, Michael J ^a  

^a MONASH UNIVERSITY   (Australia)

^b ZOETIS   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adjuvant; Antigen uptake; Liposomes; Migratory dendritic cells; Monocytes; Poly(I:C); Vaccination

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYINOSINIC POLYCYTIDYLIC ACID;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CANNULATION; CELL MATURATION; DENDRITIC CELL; DRUG FORMULATION; GENE EXPRESSION REGULATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; LYMPH NODE; LYMPH VESSEL; LYMPHOCYTE; MONOCYTE; NEUTROPHIL; NONHUMAN; UPREGULATION; VACCINATION; VIRUS GENE; ANIMAL; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; IMMUNOLOGY; INNATE IMMUNITY; LYMPH; METABOLISM; SHEEP;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD86; CELL DIFFERENTIATION; CELL MOVEMENT; DENDRITIC CELLS; IMMUNITY, INNATE; LIPOSOMES; LYMPH; LYMPH NODES; MONOCYTES; NEUTROPHILS; POLY I-C; SHEEP;

EID: 84907983226     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.09.036     Document Type: Article

References (33)

1. Ishii K.J., Akira S. Toll or toll-free adjuvant path toward the optimal vaccine development. J Clin Immunol 2007, 27(4 (Jul)):363-371.
2. Coffman R.L., Sher A., Seder R.A. Vaccine adjuvants: putting innate immunity to work. Immunity 2010, 33(4(Oct 29)):492-503.
3. Longhi M.P., Trumpfheller C., Idoyaga J., Caskey M., Matos I., Kluger C., et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 2009, 206(7(Jul 6)):1589-1602.
4. Trumpfheller C., Caskey M., Nchinda G., Longhi M.P., Mizenina O., Huang Y., et al. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc Natl Acad Sci USA 2008, 105(7(Feb 19)):2574-2579.
5. Salem M.L., El-Naggar S.A., Kadima A., Gillanders W.E., Cole D.J. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu. Vaccine 2006, 24(24(Jun 12)):5119-5132.
6. Park H., Adamson L., Ha T., Mullen K., Hagen S.I., Nogueron A., et al. Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates. J Immunol 2013, 190(8(Apr 15)):4103-4115.
7. Cao Y., Lu Z., Li Y., Sun P., Li D., Li P., et al. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs. Antiviral Res 2013, 97(2(Feb)):145-153.
8. Lonez C., Vandenbranden M., Ruysschaert J.M. Cationic liposomal lipids: from gene carriers to cell signalling. Prog Lipid Res 2008, 47(5(Sep)):340-347.
9. Ma Y.F., Zhuang Y., Xie X.F., Wang C., Wang F., Zhou D.M., et al. The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses. Nanoscale 2011, 3(5):2307-2314.
10. Zhang Y.M., Rusckowski M., Liu N., Liu C., Hnatowich D.J. Cationic liposomes enhance cellular/nuclear localization of 99mTc-antisense oligonucleotides in target tumor cells. Cancer Biother Radiopharm 2001, 16(5(Oct)):411-419.
11. De Oliveira M.C., Boutet V., Fattal E., Boquet D., Grognet J.M., Couvreur P., et al. Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice. Life Sci 2000, 67(13 (Aug 18)):1625-1637.
12. Wang C., Zhuang Y., Zhang Y.J., Luo Z.C., Gao N.N., Li P., et al. Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3-IRF3 signaling and type I interferons in dendritic cells. Vaccine 2012, 30(32(Jul 6)):4790-4799.
13. Shargh V.H., Jaafari M.R., Khamesipour A., Jaafari I., Jalali S.A., Abbasi A., et al. Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis. Vaccine 2012, 30(26(Jun 6)):3957-3964.
14. Brandt L., Elhay M., Rosenkrands I., Lindblad E.B., Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun 2000, 68(2(Feb)):791-795.
15. Nordly P., Madsen H.B., Nielsen H.M., Foged C. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators. Expert Opin Drug Deliv 2009, 6(7(Jul)):657-672.
16. Neeland M.R., Meeusen E.N., de Veer M.J. Afferent lymphatic cannulation as a model system to study innate immune responses to infection and vaccination. Vet Immunol Immunopathol 2014, 158(1-2(Mar 15)):86-97.
17. de Veer M., Kemp J., Chatelier J., Elhay M.J., Meeusen E.N. Modulation of soluble and particulate antigen transport in afferent lymph by monophosphoryl lipid A. Immunol Cell Biol 2012, 90(4(Apr)):404-410.
18. Neeland M.R., Elhay M.J., Nathanielsz J., Meeusen E.N., de Veer M.J. Incorporation of CpG into a liposomal vaccine formulation increases the maturation of antigen-loaded dendritic cells and monocytes To improve local and systemic immunity. J Immunol 2014, 192(8):3666-3675.
19. Knuehl C., Seelig A., Brecht B., Henklein P., Kloetzel P.M. Functional analysis of eukaryotic 20S proteasome nuclear localization signal. Exp Cell Res 1996, 225(1(May 25)):67-74.
20. Zaks K., Jordan M., Guth A., Sellins K., Kedl R., Izzo A., et al. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J Immunol 2006, 176(12(Jun 15)):7335-7345.
21. Egan P.J., Kimpton W., Seow H.F., Bowles V.M., Brandon M.R., Nash A.D. Inflammation-induced changes in the phenotype and cytokine profile of cells migrating through skin and afferent lymph. Immunology 1996, 89(4(Dec)):539-546.
22. de Veer M., Neeland M., Burke M., Pleasance J., Nathanielsz J., Elhay M., et al. Cell recruitment and antigen trafficking in afferent lymph after injection of antigen and poly(I:C) containing liposomes, in aqueous or oil-based formulations. Vaccine 2013, 31(7(Feb 4)):1012-1018.
23. Caskey M., Lefebvre F., Filali-Mouhim A., Cameron M.J., Goulet J.P., Haddad E.K., et al. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med 2011, 208(12(Nov 21)):2357-2366.
24. Nordly P., Rose F., Christensen D., Nielsen H.M., Andersen P., Agger E.M., et al. Immunity by formulation design: induction of high CD8(+) T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method. J Control Release 2011, 150(3(Mar 30)):307-317.
25. de Veer M., Kemp J., Chatelier J., Elhay M.J., Meeusen E.N. The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant. Vaccine 2010, 28(40(Sep 14)):6597-6602.
26. Fossum C., Hjertner B., Ahlberg V., Charerntantanakul W., McIntosh K., Fuxler L., et al. Early inflammatory response to the saponin adjuvant Matrix-M in the pig. Vet Immunol Immunopathol 2014, 158(1-2(Mar 15)):53-61.
27. Contreras V., Urien C., Guiton R., Alexandre Y., Vu Manh T.P., Andrieu T., et al. Existence of CD8alpha-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J Immunol 2010, 185(6(Sep 15)):3313-3325.
28. Milling S.W.F., Jenkins C.D., Yrlid U., Cerovic V., Edmond H., McDonald V., et al. Steady-state migrating intestinal dendritic cells induce potent inflammatory responses in naive CD4(+) T cells. Mucosal Immunol 2009, 2(2(Mar)):156-165.
29. Nalubamba K.S., Gossner A.G., Dalziel R.G., Hopkins J. Differential expression of pattern recognition receptors in sheep tissues and leukocyte subsets. Vet Immunol Immunopathol 2007, 118(3-4(Aug 15)):252-262.
30. Jelinek I., Leonard J.N., Price G.E., Brown K.N., Meyer-Manlapat A., Goldsmith P.K., et al. TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol 2011, 186(4(Feb 15)):2422-2429.
31. Kumar H., Koyama S., Ishii K.J., Kawai T., Akira S. Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol 2008, 180(2(Jan 15)):683-687.
32. de Veer M.J., Holko M., Frevel M., Walker E., Der S., Paranjape J.M., et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 2001, 69(6(Jun)):912-920.
33. Joseph A., Louria-Hayon I., Plis-Finarov A., Zeira E., Zakay-Rones Z., Raz E., et al. Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines. Vaccine 2002, 20(27-28(Sep 10)):3342-3354.